Bifidobacterium bifidum (B. bifidum)

Bifidobacterium bifidum is a Gram-positive, anaerobic bacterium commonly found in the human gastrointestinal tract—especially abundant in infants—and also present in breast milk and the vagina. As one of the most prevalent probiotics naturally inhabiting mammals' intestines, it plays key roles in maintaining healthy gut flora by fermenting carbohydrates into lactic acid and acetic acid, inhibiting pathogen growth through environmental acidification, supporting digestion (including lactose breakdown), modulating immune function by influencing cytokine production and antibody levels, degrading mucin glycoproteins unique among many gut microbes, reducing inflammation, alleviating symptoms associated with irritable bowel syndrome, preventing some allergic conditions like eczema, improving mental health via the gut-brain axis, and potentially serving innovative roles such as targeted drug/gene delivery vehicles within tumor microenvironments. While not itself considered a classical molecular target like receptors or enzymes—and thus not directly "targeted" by drugs—it has significant clinical relevance both through its natural biological activities when administered orally ("probiotic") and emerging applications leveraging its unique properties for advanced therapies.

Other names

B. bifidumProbiotic Bifidobacterium

For its use as a probiotic: - Competes with pathogenic bacteria for nutrients and adhesion sites. - Produces acids that lower gut pH and inhibit pathogens. - Modulates host immune responses by stimulating immunoglobulin production and regulating cytokines. For experimental cancer therapy: - Acts as carrier for targeted drug/gene delivery to hypoxic tumor microenvironments due to preferential colonization there; can be engineered to express therapeutic proteins or serve imaging/monitoring functions within tumors.